Filing Details
- Accession Number:
- 0000899243-19-006351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 21:30:38
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 21:30:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642355 | Ltd. Braslyn | Cay House, Ep Taylor Drive Lyford Cay, New Providence C5 N7776 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-03-01 | 275,000 | $69.00 | 2,860,966 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-03-01 | 275,004 | $0.00 | 3,135,970 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-01 | 4 | $72.80 | 3,135,966 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to purchase) | Disposition | 2019-03-01 | 275,004 | $5.60 | 275,004 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,590,426 | 2017-01-06 | No | 4 | M | Direct |
Footnotes
- These securities are owned directly by Braslyn Ltd. ("Braslyn") which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Joe Lewis, (vi) Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake, and (xi) Christopher Fuglesang (collectively, the "Boxer Group). Joe Lewis is the sole indirect beneficial owner of and controls Braslyn.
- The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.
Billionaire Hedge Funds
